Dafna Capital Management LLC / DAWNGBX
Dafna Capital Management LLC’s Day One Biopharmaceuticals I Position
Does Dafna Capital Management LLC own Day One Biopharmaceuticals I (DAWNGBX)? Yes — 978.5K shares worth $21M (+4.77% of its 13F portfolio) as of Q1 2026, down from 999.2K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
978.5K
% of Portfolio
+4.77%
Quarters Held
12
currently held
Position History DAWNGBX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 978.5K | $21M | +4.77% |
| Q4 2025 | 999.2K | $9M | +2.16% |
| Q3 2025 | 999.2K | $7M | +1.74% |
| Q2 2025 | 879.2K | $6M | +1.58% |
| Q1 2025 | 731.4K | $6M | +1.64% |
| Q4 2024 | 731.4K | $9M | +2.36% |
| Q3 2024 | 750.4K | $10M | +2.47% |
| Q2 2024 | 666.5K | $9M | +2.19% |
| Q1 2024 | 666.5K | $11M | +2.51% |
| Q4 2023 | 686.5K | $10M | +2.40% |
| Q3 2023 | 586.5K | $7M | +2.24% |
| Q2 2023 | 507.1K | $6M | +1.66% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dafna Capital Management LLC’s full portfolio or all institutional holders of DAWNGBX.